The Centers for Disease Control and Prevention recommends everyone six years and older receive the updated shots.

A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...

The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...

Friday, the FDA granted Emergency Use Authorization to Novavax Inc.’s (NASDAQ:NVAX) COVID-19 Vaccine, Adjuvanted (2024-2025 ...

The Food and Drug Administration (FDA) granted emergency use authorization for an updated version of the Novavax COVID-19 ...

Which brings us to today. The US Food and Drug Administration (FDA) has just approved an updated version of Novavax’s ...

(Reuters) -The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of ...

(RTTNews) - Novavax, Inc. (NVAX), Friday announced that the ... in favor of a universal recommendation for the use of 2024-2025 COVID-19 vaccines authorized under EUA or approved by Biologics License ...

Also Read: FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax’s Shot. “Our updated vaccine targets JN.1, the ‘parent strain’ of currently circulating ...

The US Food and Drug Administration (FDA) has given Novavax emergency use authorization to update its COVID-19 vaccine for patients 12 years and older.Josh Lipton and Madison Mills monitor Novavax ...